Research article Curcuma aromatica rhizomes ethanol extract: A potential therapeutic agent against HepG2 Hepatoma cells
English
DOI:
https://doi.org/10.14719/pst.3362Keywords:
antioxidant activity, Curcuma aromatica Salisb, curcumol, extraction, phytochemical screeningAbstract
Curcuma aromatica, a Vietnamese medicinal plant, exhibits diverse therapeutic applications including blood loss, blood stasis, bloody urination, bloody vomiting, irregular menstruation, epilepsy, and cancer treatment. C. aromatica rhizomes ethanol extract and curcumol content have been shown strong inhibition of cancer growth. HepG2 cells were exposed to different doses of ethanol extract and curcumol extract. The degree of cell growth inhibition was determined using the WST-1 assay, and Hoechst 33258 spectrofluorometric assay, while the rate of cell death by apoptosis was assessed using the annexin-propidium iodide double-staining assay. Flow cytometry was employed to study the cell cycle, while the transwell assay was used to assess cell migration and invasion. The expression of bax and bcl-2 genes was analyzed using real-time reverse transcription-PCR. C. aromatica rhizomes ethanol extract (CE) consisted of a total phenolic content value of 15.02±0.18 (mg/g extract) and a curcumol level of 849.8 ± 23.73 (?g/g extract). The growth of HepG2 cells was suppressed in a dose-dependent manner by C. aromatica rhizomes ethanol extract. Following a 72-hour exposure to an (CE) concentration of 100 ?g/mL, the inhibition rate was measured to be 34.559 ± 0.456 %, the IC50 value was determined to be 44.79 ?g/mL and the inhibition of curcumol was 50.961± 0.641 %, and the IC50=93.48. The application of CE induced late apoptosis in HepG2 cells. The CE also induced programmed cell death (apoptosis) in HepG2 cancer cells, effectively suppressing their growth, movement, and invasion by controlling the synthesis of Bcl-2 mRNA. This work gives novel insights into the antihepatoma action of (CE) and establishes a foundation for the development of preliminary anticancer medications.
Downloads
References
Huang Q, Lin K, Lin Z, Ji H, Zhou X, Wang B, et al. Prognosis value of microscopic bile duct invasion in hepatocellular carcinoma: A multicenter study. Cancer Medicine. 2023;12(22):20821-9.
Russo FP, Zanetto A, Pinto E, Battistella S, Penzo B, Burra P, et al. Hepatocellular carcinoma in chronic viral hepatitis: where do we stand? International Journal of Molecular Sciences. 2022;23(1):500.
Bogentoft C, Ericsson O, Kvist M, Danielsson B. Studies on the medicinal chemistry of oxoquinazolines. XI. Synthesis of 1-methyl-3-substituted 1, 2, 3, 4-tetrahydro-4-oxoquinazolines. Acta Pharmaceutica Suecica. 1971;8(6):667-70.
Pessino G, Scotti C, Maggi M, Consortium I-H. Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets. Cancers. 2024;16(5):901.
Klein S, Dufour J-F. Nonalcoholic fatty liver disease and hepatocellular carcinoma. Hepatic Oncology. 2017;4(3):83-98.
Sun W, Wang S, Zhao W, Wu C, Guo S, Gao H, et al. Chemical constituents and biological research on plants in the genus Curcuma. Critical Reviews in Food Science and Nutrition. 2017;57(7):1451-523.
Sikha A, Harini A. Pharmacological activities of wild turmeric (Curcuma aromatica Salisb): a review. Journal of Pharmacognosy and Phytochemistry. 2015;3(5):01-4.
Priyanka R, Vasundhara M, Ah M. Chemo-profiling of Curcuma aromatica Salisbury rhizomes and leaves from South India. J Med Plants Stud. 2019;7:260-2.
Zhang W, Wang Z, Chen T. Curcumol induces apoptosis via caspases-independent mitochondrial pathway in human lung adenocarcinoma ASTC-a-1 cells. Medical Oncology. 2011;28:307-14.
Ning L, Ma H, Jiang Z, Chen L, Li L, Chen Q, et al. Curcumol suppresses breast cancer cell metastasis by inhibiting MMP-9 via JNK1/2 and Akt-dependent NF-?B signaling pathways. Integrative Cancer Therapies. 2016;15(2):216-25.
Li X, Liu H, Wang J, Qin J, Bai Z, Chi B, et al. Curcumol induces cell cycle arrest and apoptosis by inhibiting IGF?1R/PI3K/Akt signaling pathway in human nasopharyngeal carcinoma CNE?2 cells. Phytotherapy Research. 2018;32(11):2214-25.
Nguyen QB. Th?c V?t Chí Vi?t Nam. Flora of Vietnam 21 Nha? xua??t ba?n khoa ho?c va? ky? thua??t, Ha? No??i. 2017.
Singleton VL, Orthofer R, Lamuela-Raventós RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent. Methods in Enzymology. 299: Elsevier; 1999. p. 152-78.
Cao L, Wan R, Wang Y. Determination of curcumol and germacrone in zedoary turmeric oil injections by RP-HPLC. Chinese Journal of Biochemical Pharmaceutics. 2007;28(6):394.
Majtnerova P, Capek J, Petira F, Handl J, Rousar T. Quantitative spectrofluorometric assay detecting nuclear condensation and fragmentation in intact cells. Scientific Reports. 2021;11(1):11921.
Kumar R, Saneja A, Panda AK. An annexin V-FITC—propidium iodide-based method for detecting apoptosis in a non-small cell lung cancer cell line. Lung Cancer: Methods and Protocols. 2021:213-23.
Burapan S, Kim M, Paisooksantivatana Y, Eser BE, Han J. Thai Curcuma species: Antioxidant and bioactive compounds. Foods. 2020;9(9):1219.
Ahmad S, Ali M, Ansari SH, Ahmed F. Phytoconstituents from the rhizomes of Curcuma aromatica Salisb. Journal of Saudi Chemical Society. 2011;15(3):287-90.
Huang K, Tao Z, Zhang A, Peng S, Ding L. Studies on chemical constituents of Curcuma aromatica salisb. China Journal of Chinese Materia Medica. 2000;25(3):163-5.
Hashem S, Nisar S, Sageena G, Macha MA, Yadav SK, Krishnankutty R, et al. Therapeutic effects of curcumol in several diseases; an overview. Nutrition and Cancer. 2021;73(2):181-95.
Li Y, Shi X, Zhang J, Zhang X, Martin RC. Hepatic protection and anticancer activity of curcuma: A potential chemopreventive strategy against hepatocellular carcinoma. International Journal of Oncology. 2014;44(2):505-13.
Huang F, Yang Z, Yu D, Wang J, Li R, Ding G. Sepia ink oligopeptide induces apoptosis in prostate cancer cell lines via caspase-3 activation and elevation of Bax/Bcl-2 ratio. Marine Drugs. 2012;10(10):2153-65.
Cahyadi A, Ugrasena IDG, Andarsini MR, Larasati MCS, Aryati A, Arumsari DK. Relationship between bax and bcl-2 protein expression and outcome of induction phase chemotherapy in pediatric acute lymphoblastic leukemia. Asian Pacific Journal of Cancer Prevention. 2022;23(5):1679.
Downloads
Published
Versions
- 17-05-2024 (2)
- 07-05-2024 (1)
How to Cite
Issue
Section
License
Copyright (c) 2024 Dinh Thach Bui, Chinh Chung Doan , Thi Linh-Giang Tran, Thi-Ben Trinh, Thi Dung Le, Thi Kim-Khanh Le, Quang-Dao Vu, Nguyen Tu-Linh Le, Thien-Hoang Ho
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright and Licence details of published articles
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Open Access Policy
Plant Science Today is an open access journal. There is no registration required to read any article. All published articles are distributed under the terms of the Creative Commons Attribution License (CC Attribution 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited (https://creativecommons.org/licenses/by/4.0/). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
